An Evening with the University of Minnesota's Brain Tumor Program

Click to see photos from the dinner hosted by the UMN Brain Tumor Program. Dr. Sloan attended this dinner held on May 29, 2024.

ResearcHERS Rising Star 2024

Lindsey Sloan was awarded the American Cancer Society's ResearcHERS "Rising Star" on May 20, 2024.

Dr. Sloan Rising Star
Rising Star

Neuro-Oncology Innovation Challenge 2024

Lindsey Sloan participated as a moderator during the Neuro-Oncology Innovation Challenge held in Minneapolis, Minnesota April 22-23, 2024.

Masonic Cancer Center MINI Research Symposium 2024

Lindsey Sloan spoke as part of the Career Development Panel at the Masonic Cancer Center MINI Research Symposium held April 16, 2024 in Minneapolis, MN.

MINI Research Symposium
MINI Research Symposium 2

University of Minnesota Foundation Research grant

Isabella Wedes was awarded a University of Minnesota Foundation Research grant of $3000 for her summer research project titled "Comparison of Myeloid-derived Suppressor Cells Immediately before and after a Fraction of Radiotherapy." Bella will be working on this project in the Sloan Laboratory this summer. Congratulations!

MSCO 2024 Spring Conference Poster Presentation and Award

Congrats to Subbu Mishra and the entire team for their poster award of $1500 at the Minnesota Society of Clinical Oncology (MSCO) Spring Conference! Poster details:
Mishra, S., Berkseth, M., Golden, L., Bergerud, K.B., Wieworka, J., Sando, N., Lawrence, J., Chen, L., Ozutemiz, C., Neil, E., Ganguly, S., Kleinberg, L.R., Dusenbery, K.E., Venteicher, A., Yuan, J., Terezakis, S.A., Sloan, L. (2024). Radiotherapy's Role in Modulating Immune Response in Meningioma.

Lindsey Sloan, MD, PhD named Principal Investigator of three clinical trials

  • A Multicenter Observational Study of GammaTile Surgically Targeted Radiation Therapy (STaRT) in Intracranial Brain Neoplasms (GTM-101)
  • A Phase 3 Randomized Controlled Trial of Post-Surgical Stereotactic Radiotherapy (SRT) versus Surgically Targeted Radiation Therapy (STaRT) with Gamma Tile for Treatment of Newly Diagnosed Metastatic Brain Tumors (GTM-102)
  • Feasibility Study of Resection and GammaTile┬« Followed by Concomitant External Beam Radiation Therapy (EBRT) and Temozolomide (TMZ) and Adjuvant TMZ in Newly Diagnosed Glioblastoma (GBM) (GTM-103)

Poster Presentation at UMN Fall Undergraduate Research Symposium 2023

Congratulations to Kyra Boorsma Bergerud on her poster presentation "Differences in Conventionally Fractionated vs. Ablative Radiation Exposure on Immune Cell Composition and Activation in Meningioma".

Poster Presentations at ASTRO 2023

Congratulations to Matt Berkseth, who presented two posters from the Sloan Lab group at the 2023 ASTRO Annual Meeting! Poster details:

Lindsey Greenlund, Matt Berkseth, Ryan Shanley, Nicole Sando, Lydia Golden, Jennifer Wieworka, Kyra Boorsma Bergerud, Michael Olin, G. Elizabeth Pluhar, Susan Arnold, Jessica Lawrence, Andrew Venteicher, Clark Chen, Clara Ferreira, Elizabeth Neil, Kathryn Dusenbery, Sudipto Ganguly, Lawrence Kleinberg, Stephanie Terezakis, Lindsey Sloan. The Effects of Adjuvant Chemoradiotherapy (CRT) on Myeloid-derived Suppressor Cell (MDSC) Subsets in Glioblastoma (GBM). doi: 10.1016/j.ijrobp.2023.06.1148

Kelsey Wanhainen, Matt Berkseth, Nicole Sando, Lydia Golden, Amy Techam, Jenn Wieworka, Kyra Boorsma Bergerud, Peter Argenta, Andrea O'Shea, Colleen Rivard, Rahel Ghebre, Deanna Teoh, Margaret Reynolds, Stephanie Terezakis, Jianling Yuan, Lindsey Sloan. Effect of External Beam Radiation Therapy (EBRT) and Brachytherapy (BT) on Circulating MDSC Populations in Patients Treated Definitively for Cervical Cancer. doi:10.1016/j.ijrobp.2023.06.1864

Maximizing the impact of radiation therapy: Q&A with Masonic Scholar Lindsey Sloan, MD, PhD

With Masonic Scholar Support, Lindsey Sloan, radiation oncology faculty member and one of the University's newest recruits, is dedicating her work in the Masonic Discovery Lab to personalizing and maximizing the effectiveness of radiation therapy for people affected by brain tumors.